Literature DB >> 24218455

A role for IRF8 in B cell anergy.

Simanta Pathak1, Shibin Ma, Vipul Shukla, Runqing Lu.   

Abstract

B cell central tolerance is a process through which self-reactive B cells are removed from the B cell repertoire. Self-reactive B cells are generally removed by receptor editing in the bone marrow and by anergy induction in the periphery. IRF8 is a critical transcriptional regulator of immune system development and function. A recent study showed that marginal zone B cell and B1 B cell populations are dramatically increased in IRF8-deficient mice, indicating that there are B cell-developmental defects in the absence of IRF8. In this article, we report that mice deficient for IRF8 produced anti-dsDNA Abs. Using a hen egg lysozyme double-transgenic model, we further demonstrate that B cell anergy was breached in IRF8-deficient mice. Although anergic B cells in the IRF8-proficient background were blocked at the transitional stage of development, anergic B cells in the IRF8-deficient background were able to mature further, which allowed them to regain responses to Ag stimulation. Interestingly, our results show that IRF8-deficient B cells were more sensitive to Ag stimulation and were resistant to Ag-induced cell death. Moreover, our results show that IRF8 was expressed at a high level in the anergic B cells, and an elevated level of IRF8 promoted apoptosis in the transitional B cells. Thus, our findings reveal a previously unrecognized function of IRF8 in B cell anergy induction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218455      PMCID: PMC3864091          DOI: 10.4049/jimmunol.1301169

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.

Authors:  T Tamura; T Nagamura-Inoue; Z Shmeltzer; T Kuwata; K Ozato
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

Review 2.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

4.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

Authors:  Robin Lesley; Ying Xu; Susan L Kalled; Donna M Hess; Susan R Schwab; Hong-Bing Shu; Jason G Cyster
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  NFATc1 and NFATc2 together control both T and B cell activation and differentiation.

Authors:  S L Peng; A J Gerth; A M Ranger; L H Glimcher
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

6.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

Authors:  I M de Alboran; R C O'Hagan; F Gärtner; B Malynn; L Davidson; R Rickert; K Rajewsky; R A DePinho; F W Alt
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

7.  Protein kinase Cdelta controls self-antigen-induced B-cell tolerance.

Authors:  Ingrid Mecklenbräuker; Kaoru Saijo; Nai-Ying Zheng; Michael Leitges; Alexander Tarakhovsky
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

8.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

9.  A role for IRF4 in the development of CLL.

Authors:  Vipul Shukla; Shibin Ma; Richard R Hardy; Shantaram S Joshi; Runqing Lu
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

10.  Autoreactive B cells in the marginal zone that express dual receptors.

Authors:  Yijin Li; Hui Li; Martin Weigert
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  11 in total

1.  Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8.

Authors:  Heping Xu; Virendra K Chaudhri; Zhiguo Wu; Konstantinos Biliouris; Krista Dienger-Stambaugh; Yrina Rochman; Harinder Singh
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

2.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

3.  Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.

Authors:  Kerstin Nündel; Nathaniel M Green; Arthur L Shaffer; Krishna L Moody; Patricia Busto; Dan Eilat; Kensuke Miyake; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

4.  Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR.

Authors:  Jeongheon Yoon; Xianxum Feng; Yong-Soo Kim; Dong-Mi Shin; Katerina Hatzi; Hongsheng Wang; Herbert C Morse
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

5.  IRF4 and IRF8: Governing the virtues of B Lymphocytes.

Authors:  Vipul Shukla; Runqing Lu
Journal:  Front Biol (Beijing)       Date:  2014-08

6.  An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Authors:  Jonathan C Poe; Wei Jia; Hsuan Su; Sarah Anand; Jeremy J Rose; Prasanthi V Tata; Amy N Suthers; Corbin D Jones; Pei Fen Kuan; Benjamin G Vincent; Jonathan S Serody; Mitchell E Horwitz; Vincent T Ho; Steven Z Pavletic; Frances T Hakim; Kouros Owzar; Dadong Zhang; Bruce R Blazar; Christian W Siebel; Nelson J Chao; Ivan Maillard; Stefanie Sarantopoulos
Journal:  Blood       Date:  2017-08-29       Impact factor: 22.113

7.  Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity.

Authors:  Prasida Holla; Brian Dizon; Abhijit A Ambegaonkar; Noga Rogel; Ella Goldschmidt; Arun K Boddapati; Haewon Sohn; Dan Sturdevant; James W Austin; Lela Kardava; Li Yuesheng; Poching Liu; Susan Moir; Susan K Pierce; Asaf Madi
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

8.  Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.

Authors:  Dong-Wen Lv; Kun Zhang; Renfeng Li
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

9.  Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.

Authors:  Venetia Bigley; Sheetal Maisuria; Urszula Cytlak; Laura Jardine; Matthew A Care; Kile Green; Merry Gunawan; Paul Milne; Rachel Dickinson; Sarah Wiscombe; David Parry; Rainer Doffinger; Arian Laurence; Claudia Fonseca; Oda Stoevesandt; Andrew Gennery; Andrew Cant; Reuben Tooze; A John Simpson; Sophie Hambleton; Sinisa Savic; Gina Doody; Matthew Collin
Journal:  J Allergy Clin Immunol       Date:  2017-11-08       Impact factor: 10.793

10.  Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery.

Authors:  Tian Zhou; Xinyi Zhu; Zhizhong Ye; Yong-Fei Wang; Chao Yao; Ning Xu; Mi Zhou; Jianyang Ma; Yuting Qin; Yiwei Shen; Yuanjia Tang; Zhihua Yin; Hong Xu; Yutong Zhang; Xiaoli Zang; Huihua Ding; Wanling Yang; Ya Guo; John B Harley; Bahram Namjou; Kenneth M Kaufman; Leah C Kottyan; Matthew T Weirauch; Guojun Hou; Nan Shen
Journal:  Nat Commun       Date:  2022-04-06       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.